Featured News

Consider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.

iCureCeliac® is the Foundation’s patient-powered tool that is the single best resource for celiac disease researchers around the world helping to accelerate the search for treatments and a cure.

The FDA released the long-awaited draft guidance, “Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet."

The month of May is Celiac Disease Awareness Month, and in an effort to bring celiac disease into the public eye, Marilyn G. Geller, Chief Executive Officer of the Celiac…

Join UChicago to discuss the best ways to use the internet when navigating the gluten-free diet and celiac disease.

We are pleased to announce that CDF Board Member, Kristin Yarema, PhD, was honored as a 2022 Medical Marketing & Media Woman of Distinction.

Join UChicago Celiac Disease Center to discuss serology and the importance of regular follow-up.

The Celiac Disease Foundation is proud to recognize our dedicated volunteers, Francie Wallack and Josh Denney.

Join UChicago Celiac Disease Center via Zoom on Monday, May 2nd, 2022 at 7:00 PM CST to kick off Celiac Awareness Month.

The Celiac Disease Foundation is in discussion with a team at the University of Colorado, Denver to develop the first-ever, FDA-approved pediatric PRO (patient-reported outcome tool).